TR-14035

CAS No. 232271-19-1

TR-14035 ( TR 14035;TR14035 )

Catalog No. M13660 CAS No. 232271-19-1

A potent, orally bioavailable, dual α4β7/α4β1 integrin antagonist with IC50 of 7/87 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 105 In Stock
5MG 160 In Stock
10MG 260 In Stock
25MG 470 In Stock
50MG 680 In Stock
100MG 954 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TR-14035
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, orally bioavailable, dual α4β7/α4β1 integrin antagonist with IC50 of 7/87 nM.
  • Description
    A potent, orally bioavailable, dual α4β7/α4β1 integrin antagonist with IC50 of 7/87 nM; blocks the binding of human α4β7 to an (125)I-MAdCAM-Ig fusion protein with IC50 of 0.75 nM; suppresses antigen-induced lung interleukin (IL)-5 mRNA upregulation, inhibits the leukocyte rolling flux, adhesion and emigration induced by IL4 in rats.Asthma Phase 1 Discontinued
  • Synonyms
    TR 14035;TR14035
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Integrin
  • Recptor
    α4β7integrin;α4β1integrin
  • Research Area
    Inflammation/Immunology
  • Indication
    Asthma

Chemical Information

  • CAS Number
    232271-19-1
  • Formula Weight
    474.33
  • Molecular Formula
    C24H21Cl2NO5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:≥ 41 mg/mL
  • SMILES
    O=C(O)[C@H](CC1=CC=C(C2=C(OC)C=CC=C2OC)C=C1)NC(C3=C(Cl)C=CC=C3Cl)=O
  • Chemical Name
    [1,1'-Biphenyl]-4-propanoic acid, α-[(2,6-dichlorobenzoyl)amino]-2',6'-dimethoxy-,(αS)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Sircar I, et al. Bioorg Med Chem. 2002 Jun;10(6):2051-66.
2. Cortijo J, et al. Br J Pharmacol. 2006 Mar;147(6):661-70.
3. Tsuda-Tsukimoto M, et al. Pharm Res. 2006 Nov;23(11):2646-56.
molnova catalog
related products
  • α2β1 integrin-IN-15

    α2β1 integrin-IN-15 highly potent, selective, allosteric small-molecule inhibitor of integrin α2β1 with IC50 of 12 nM.

  • GSK-3008348 hydrochl...

    GSK-3008348 hydrochloride is a novel potent, selective integrin αvβ6 antagonist for the treatment of idiopathic pulmonary fibrosis (IPF).

  • P11

    Potent antagonist of the integrin αvβ3-vitronectin interaction (IC50 = 25.72 nM). Blocks proliferation and induces apoptosis in HUVECs; antiangiogenic.